WO2014006261A3 - Micropartículas para encapsulación de probióticos, su obtención y usos - Google Patents

Micropartículas para encapsulación de probióticos, su obtención y usos Download PDF

Info

Publication number
WO2014006261A3
WO2014006261A3 PCT/ES2013/070477 ES2013070477W WO2014006261A3 WO 2014006261 A3 WO2014006261 A3 WO 2014006261A3 ES 2013070477 W ES2013070477 W ES 2013070477W WO 2014006261 A3 WO2014006261 A3 WO 2014006261A3
Authority
WO
WIPO (PCT)
Prior art keywords
microparticles
probiotics
encapsulation
preparation
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/ES2013/070477
Other languages
English (en)
French (fr)
Other versions
WO2014006261A2 (es
Inventor
Maite AGÜEROS BAZO
Irene ESPARZA CATALÁN
Carlos Gamazo De La Rasilla
Carolina GONZÁLEZ FERRERO
Carlos Javier GONZÁLEZ NAVARRO
Juan Manuel Irache Garreta
Rebeca PEÑALBA SOBRÓN
Ana Romo Hualde
Raquel Virto Resano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centro Nacional de Tecnologia y Seguridad Alimentaria Laboratorio del Ebro
Universidad de Navarra
Original Assignee
Centro Nacional de Tecnologia y Seguridad Alimentaria Laboratorio del Ebro
Universidad de Navarra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro Nacional de Tecnologia y Seguridad Alimentaria Laboratorio del Ebro, Universidad de Navarra filed Critical Centro Nacional de Tecnologia y Seguridad Alimentaria Laboratorio del Ebro
Priority to JP2015519259A priority Critical patent/JP6442401B2/ja
Priority to CA2878026A priority patent/CA2878026C/en
Priority to EP13760072.2A priority patent/EP2868206B1/en
Priority to US14/412,146 priority patent/US10111835B2/en
Priority to CN201380046390.XA priority patent/CN104602545B/zh
Priority to MX2015000218A priority patent/MX366411B/es
Priority to RU2015103826A priority patent/RU2015103826A/ru
Priority to AU2013285330A priority patent/AU2013285330B2/en
Priority to DK13760072.2T priority patent/DK2868206T3/en
Priority to BR112015000041-0A priority patent/BR112015000041B1/pt
Priority to KR1020157003179A priority patent/KR102203837B1/ko
Priority to ES13760072.2T priority patent/ES2606679T3/es
Publication of WO2014006261A2 publication Critical patent/WO2014006261A2/es
Publication of WO2014006261A3 publication Critical patent/WO2014006261A3/es
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/22—Compounds of alkali metals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/26—Compounds containing phosphorus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/10—Shaping or working-up of animal feeding-stuffs by agglomeration; by granulation, e.g. making powders
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La invención se dirige a unas micropartículas que comprenden una matriz constituida por caseína y quitosano, y unas bacterias probióticas; dicha matriz protege a dichas bacterias probióticas durante su (i) procesamiento, (ii) almacenamiento y (iii) tránsito a través del tracto gastrointestinal, prolongando su vida útil. La presente invención también está dirigida al método de obtención de las micropartículas y a los productos y composiciones que las incorporan.
PCT/ES2013/070477 2012-07-05 2013-07-05 Micropartículas para encapsulación de probióticos, su obtención y usos Ceased WO2014006261A2 (es)

Priority Applications (12)

Application Number Priority Date Filing Date Title
JP2015519259A JP6442401B2 (ja) 2012-07-05 2013-07-05 プロバイオティクスを封入するための微粒子、この微粒子を得ることおよびその使用
CA2878026A CA2878026C (en) 2012-07-05 2013-07-05 Microparticles for encapsulating probiotics, obtaining said microparticles and uses thereof
EP13760072.2A EP2868206B1 (en) 2012-07-05 2013-07-05 Microparticles for the encapsulation of probiotics, preparation and uses thereof
US14/412,146 US10111835B2 (en) 2012-07-05 2013-07-05 Microparticles for encapsulating probiotics, production and uses thereof
CN201380046390.XA CN104602545B (zh) 2012-07-05 2013-07-05 用于包封益生菌的微粒，获得所述微粒的方法及其用途
MX2015000218A MX366411B (es) 2012-07-05 2013-07-05 Microparticulas para encapsulacion de probioticos, su obtencion y usos.
RU2015103826A RU2015103826A (ru) 2012-07-05 2013-07-05 Микрочастица (варианты), ее включающая композиция (варианты), пищевой, фармацевтический, лечебный косметический или нутрицевтический продукт на их основе, способ приготовления иммуномодулирующей композиции с их помощью и способ получения указанной микрочастицы
AU2013285330A AU2013285330B2 (en) 2012-07-05 2013-07-05 Microparticles for the encapsulation of probiotics, preparation and uses thereof
DK13760072.2T DK2868206T3 (en) 2012-07-05 2013-07-05 Microparticles for encapsulating probiotics, manufacture and applications.
BR112015000041-0A BR112015000041B1 (pt) 2012-07-05 2013-07-05 micropartícula, método para a obtenção da mesma, composição, produto alimentar, farmacêutico, cosmecêutico ou nutracêutico e uso de uma micropartícula, composição ou produto
KR1020157003179A KR102203837B1 (ko) 2012-07-05 2013-07-05 프로바이오틱 캡슐화용 마이크로입자, 그의 제조 및 이용
ES13760072.2T ES2606679T3 (es) 2012-07-05 2013-07-05 Micropartículas para la encapsulación de probióticos, obtención y usos de las mismas

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201231058 2012-07-05
ESP201231058 2012-07-05

Publications (2)

Publication Number Publication Date
WO2014006261A2 WO2014006261A2 (es) 2014-01-09
WO2014006261A3 true WO2014006261A3 (es) 2014-03-20

Family

ID=49162167

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2013/070477 Ceased WO2014006261A2 (es) 2012-07-05 2013-07-05 Micropartículas para encapsulación de probióticos, su obtención y usos

Country Status (15)

Country Link
US (1) US10111835B2 (es)
EP (1) EP2868206B1 (es)
JP (1) JP6442401B2 (es)
KR (1) KR102203837B1 (es)
CN (1) CN104602545B (es)
AU (1) AU2013285330B2 (es)
BR (1) BR112015000041B1 (es)
CA (1) CA2878026C (es)
DK (1) DK2868206T3 (es)
ES (1) ES2606679T3 (es)
MX (1) MX366411B (es)
PL (1) PL2868206T3 (es)
PT (1) PT2868206T (es)
RU (1) RU2015103826A (es)
WO (1) WO2014006261A2 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016077190A1 (en) * 2014-11-10 2016-05-19 National Institutes Of Health Probiotic therapeutic applications
GB201507760D0 (en) * 2015-05-06 2015-06-17 Anabio Technologies Ltd Gelated microparticle suitable for oral delivery of therapeutic peptides to the lower intestine
GB201508745D0 (en) * 2015-05-21 2015-07-01 Anabio Technologies Ltd A method of producing microparticles of the type having a crosslinked, aggregated protein matrix by spray drying
FR3039990B1 (fr) * 2015-08-10 2018-07-06 Rhodia Operations Procede d'encapsulation
WO2017087234A1 (en) * 2015-11-18 2017-05-26 Empire Technology Development Llc Methods and compositions for treating and preventing dag formation
WO2017103072A1 (en) 2015-12-17 2017-06-22 Universidad De Navarra Microparticles for encapsulating probiotics, obtaining said microparticles and uses thereof
CN105535580A (zh) * 2015-12-21 2016-05-04 上海善力健生物科技有限公司 一种用于改善人体肠道菌群的生物制剂及其制备方法
CN105496971B (zh) * 2015-12-28 2018-04-03 河北科技大学 复配型生物交联剂交联壳聚糖的缓控释微球及其制备方法
WO2017209823A2 (en) 2016-03-14 2017-12-07 The University Of Chicago Injectable pastes based on oppositely charged polymer/calcium phosphate hybrid nanoparticles
CN106418547A (zh) * 2016-10-09 2017-02-22 西安创客村电子商务有限责任公司 一种益生菌微胶囊及其制备方法
CA3052134C (en) * 2017-01-31 2023-01-03 University-Industry Cooperation Group Of Kyung Hee University Novel lactic acid bacteria and use thereof
EP3578637A4 (en) * 2017-01-31 2020-12-16 University - Industry Cooperation Group of Kyung Hee University NEW LACTIC BACTERIA AND THEIR USE
CN106937737B (zh) * 2017-02-07 2019-12-03 中国农业大学 一种酪蛋白凝胶颗粒乳化剂及其制备方法和用途
WO2019014576A1 (en) * 2017-07-14 2019-01-17 The University Of Chicago LYOPHILIZED FORMULATIONS COMPRISING NANOPARTICLES AND METHODS OF LYOPHILIZATION
US11147845B2 (en) 2018-07-16 2021-10-19 ProBiora Health, LLC Foods containing beneficial oral bacteria
CA3120608A1 (en) * 2018-12-07 2020-06-11 Pivot Bio, Inc. Polymer compositions with improved stability for nitrogen fixing microbial products
WO2020176697A1 (en) * 2019-02-27 2020-09-03 Accuro Agriservices, Inc. Insect repelling compositions and methods of manufacture thereof
WO2020203667A1 (ja) * 2019-03-29 2020-10-08 三菱商事ライフサイエンス株式会社 有用微生物の菌体の保護方法
CN113993499B (zh) * 2019-04-12 2024-07-23 国际香料和香精公司 用交联剂的组合制备的可持续性核壳微胶囊
US11219612B2 (en) 2019-06-11 2022-01-11 Dremcubed, Llc Nutraceutical formulation for unblocking receptors
KR102149102B1 (ko) * 2019-07-05 2020-08-27 에스케이바이오랜드 주식회사 피부보습 및 피부재생 기능이 있는 더모바이오틱스 블록 조성물의 제조방법
JP2022548785A (ja) * 2019-09-24 2022-11-21 プロラクタ バイオサイエンス，インコーポレイテッド 炎症性疾患及び免疫疾患の治療のための組成物及び方法
CN111544322A (zh) * 2020-06-04 2020-08-18 广群化妆品科学技术研究院(广州)有限公司 一种干酪乳杆菌核壳体化妆品原料及其制备方法
US11426353B2 (en) 2020-06-24 2022-08-30 13400719 Canada Inc. Composite coating for an active agent
US20230323332A1 (en) * 2020-08-28 2023-10-12 Chr. Hansen A/S Microencapsulation of microbial culture using octenyl succinic anhydride starch-chitosan complex coacervate
CN112826836A (zh) * 2021-01-08 2021-05-25 深圳未知君生物科技有限公司 一种粪菌口服制剂及其制备方法
KR102334386B1 (ko) * 2021-01-22 2021-12-01 김향숙 유산균이 함유된 배설물 악취 방지용 기능성 사료의 제조방법
KR102682973B1 (ko) * 2021-05-17 2024-07-09 가천대학교 산학협력단 프탈레이트 환경 호르몬 제거를 위한 유산균-키토산 복합체 및 이의 제조방법
WO2023059952A1 (en) * 2021-10-05 2023-04-13 Massachusetts Institute Of Technology Protection of next-generation probiotics during processing
CN114794484A (zh) * 2022-03-21 2022-07-29 宁波大学 一种乳酪蛋白微胶囊、制备方法及应用
CN115088732B (zh) * 2022-06-24 2024-12-06 大连益丰农生物科技有限公司 一种含有植物根际促生菌微胶囊的种衣剂及其制备方法
CN115399461A (zh) * 2022-08-30 2022-11-29 常熟理工学院 一种益生菌缓释果冻及其制备方法和应用
CN117481312A (zh) * 2023-11-08 2024-02-02 河南尚品食品有限公司 一种低温肉制品中添加益生菌的制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6159504A (en) * 1999-01-11 2000-12-12 Kitii Corporation, Ltd. Core substance-containing calcium microparticles and methods for producing the same
WO2002094224A1 (en) * 2001-05-23 2002-11-28 Institut National De La Recherche Scientifique Biocompatible compositions as carriers or excipients for pharmaceutical and nutraceutical formulations and for good protection
US20070020328A1 (en) * 2005-07-07 2007-01-25 Jhy-Jhu Lin Probiotics as alternative medicines against infectious diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9004950D0 (en) * 1990-03-06 1990-05-02 Kelco Int Ltd Controlled release formulation
US8871266B2 (en) 2003-10-01 2014-10-28 Commonwealth Scientific & Industrial Research Organisation Probiotic storage and delivery
CN1319637C (zh) 2003-10-15 2007-06-06 中国科学院过程工程研究所 一种尺寸均一的壳聚糖微球和微囊及其制备方法
CN101172118A (zh) * 2006-07-26 2008-05-07 美国医迈科技有限公司 作为抗传染病替代药物的益生微生物
EP2117354B1 (en) * 2006-12-18 2018-08-08 Advanced BioNutrition Corp. A dry food product containing live probiotic
PL2529004T3 (pl) 2010-01-28 2017-12-29 Advanced Bionutrition Corporation Sucha szklista kompozycja zawierająca bioaktywny materiał
AR082682A1 (es) 2010-08-13 2012-12-26 Advanced Bionutrition Corp Composicion estabilizadora de almacenamiento en seco para materiales biologicos

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6159504A (en) * 1999-01-11 2000-12-12 Kitii Corporation, Ltd. Core substance-containing calcium microparticles and methods for producing the same
WO2002094224A1 (en) * 2001-05-23 2002-11-28 Institut National De La Recherche Scientifique Biocompatible compositions as carriers or excipients for pharmaceutical and nutraceutical formulations and for good protection
US20070020328A1 (en) * 2005-07-07 2007-01-25 Jhy-Jhu Lin Probiotics as alternative medicines against infectious diseases

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BAYOMI M A ET AL: "PREPARATION OF CASEIN-CHITOSAN MICROSPHERES CONTAINING DILTIAZEM HYDROCHLORIDE BY AN AQUEOUS COACERVATION TECHNIQUE", PHARMACEUTICA ACTA HELVETIAE, ELSEVIER BV, NETHERLANDS, vol. 73, no. 4, 1 December 1998 (1998-12-01), pages 187 - 192, XP001055119, ISSN: 0031-6865, DOI: 10.1016/S0031-6865(98)00020-X *
HEIDEBACH T ET AL: "Influence of casein-based microencapsulation on freeze-drying and storage of probiotic cells", JOURNAL OF FOOD ENGINEERING, BARKING, ESSEX, GB, vol. 98, no. 3, 1 June 2010 (2010-06-01), pages 309 - 316, XP026910919, ISSN: 0260-8774, [retrieved on 20100107], DOI: 10.1016/J.JFOODENG.2010.01.003 *

Also Published As

Publication number Publication date
KR20150034243A (ko) 2015-04-02
RU2015103826A (ru) 2016-08-27
US20150335577A1 (en) 2015-11-26
CN104602545B (zh) 2017-11-17
CA2878026C (en) 2021-11-09
EP2868206B1 (en) 2016-09-14
BR112015000041B1 (pt) 2020-11-03
AU2013285330A1 (en) 2015-02-26
PT2868206T (pt) 2016-12-16
DK2868206T3 (en) 2017-01-09
WO2014006261A2 (es) 2014-01-09
AU2013285330B2 (en) 2016-04-21
CA2878026A1 (en) 2014-01-09
CN104602545A (zh) 2015-05-06
JP6442401B2 (ja) 2018-12-26
KR102203837B1 (ko) 2021-01-15
MX2015000218A (es) 2015-08-14
US10111835B2 (en) 2018-10-30
PL2868206T3 (pl) 2017-03-31
EP2868206A2 (en) 2015-05-06
JP2015527308A (ja) 2015-09-17
BR112015000041A2 (pt) 2018-05-15
ES2606679T3 (es) 2017-03-27
MX366411B (es) 2019-07-05

Similar Documents

Publication Publication Date Title
WO2014006261A3 (es) Micropartículas para encapsulación de probióticos, su obtención y usos
WO2013026033A3 (en) Strains and methods useful for mycotoxins
PT2594140T (pt) Nanopartículas para encapsulamento de compostos, sua produção e utilizações
IL219801A (en) Anti-a4 antibody. 4c isolates, vectors encoded by them, methods of preparation, preparations containing them and their use
IL226383A0 (en) Antibodies against ccl20, preparations containing them and their uses
PL2552801T3 (pl) Pakowanie, sposób wytwarzania opakowania
SG10201508826YA (en) Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
HK1207665A1 (en) Polypeptides having transgalactosylating activity
EP4553149A3 (en) Liver organoid, uses thereof and culture method for obtaining them
WO2012009315A3 (en) Bovine milk oligosaccharides
WO2010103374A3 (en) Oily suspension containing probiotic bacteria for paradiatric uses
UA113059C2 (xx) Протимікробна композиція на основі штамів lactobacillus rhamnosus, lactobacillus paracasei
EP2567624A4 (en) METHOD FOR CONNECTING A FOOD PRODUCT AND FOOD PRODUCT
IL226270A0 (en) History of hydroxamic acid, preparations containing them and their uses
WO2010117738A3 (en) Solid state forms of sitagliptin salts
PL2540169T3 (pl) Nanocząstki do kapsułkowania związków, ich otrzymywanie i zastosowanie
WO2012068441A3 (en) Intedanib salts and solid state forms thereof
WO2012016683A3 (en) Oral dosage form of pregabalin
EP2639255A4 (en) Polylactic acid resin, preparation method thereof, and packaging film comprising same
WO2012035283A8 (en) Pharmaceutical composition
EP2659790A4 (en) Food containing milk ceramide, and process for production thereof
ZA201304245B (en) Non-replicating probiotic micro-organisms protect children against gastrointestinal infections
WO2013190274A3 (en) Biodegradable compositions
ZA201304301B (en) Compositions based on clay and bee pollen,method for preparing same,and nutritional and therapeutic uses thereof
PL2701532T3 (pl) Enkapsulowany kwas, sposób jego przygotowania oraz zawierająca go guma do żucia

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13760072

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
ENP Entry into the national phase

Ref document number: 2878026

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2015519259

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 14412146

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: MX/A/2015/000218

Country of ref document: MX

REEP Request for entry into the european phase

Ref document number: 2013760072

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2013760072

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 20157003179

Country of ref document: KR

Kind code of ref document: A

Ref document number: 2015103826

Country of ref document: RU

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2013285330

Country of ref document: AU

Date of ref document: 20130705

Kind code of ref document: A

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13760072

Country of ref document: EP

Kind code of ref document: A2

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112015000041

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112015000041

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20150102